
Biotech firm gets US$33M boost for Ottawa-developed COVID-19 vaccine targeting new variants
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.
Biotech firm gets US$33M boost for Ottawa-developed COVID-19 vaccine targeting new variants
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
AI and data Governance: 3 steps to kick-start your journey
Cultural Differences and Conflict Resolution in Global Teams
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall